Physician profile
Jorge E Casas
NPI 1013951110
$209,579.91
in general payments reported to CMS, 2019-2025
11 companies · $56K in 2025
The $56K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $2,750 · 2021: $32K · 2022: $5,143 · 2023: $36K · 2024: $57K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $146K · Food and Beverage: $2,283 · Travel and Lodging: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $145,579.00 |
| Food and Beverage | $2,282.61 |
| Travel and Lodging | $879.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Onkos Surgical, INC. | $192,896.02 | 2019-2025 | Eleos Limb Salvage System |
| Biocomposites INC | $15,600.00 | 2019 | |
| Linkbio Corp | $371.72 | 2025 | |
| Depuy Synthes Sales INC. | $246.72 | 2019-2024 | |
| Restor3d, INC. | $161.91 | 2024 | |
| Wound Management Technologies, INC | $113.44 | 2019 | |
| Ossur Americas, INC. | $91.49 | 2025 | |
| Stryker Corporation | $36.05 | 2025 | Ortholoc Sps |
| Pylant Medical | $24.54 | 2021 | |
| Ethicon US, LLC | $23.52 | 2024 | Vistaseal |
| Medical Device Business Services, INC. | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Casas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.